达安基因

- 002030

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
达安基因(002030) 利润表
单位:万元
报表日期2022-03-312021-12-312021-09-302021-06-302021-03-31
一、营业总收入336,217.61766,426.22563,714.56348,271.97233,988.50
营业收入336,217.61766,426.22563,714.56348,271.97233,988.50
二、营业总成本139,601.18360,039.81262,366.02167,578.41101,656.67
营业成本82,021.43193,407.91138,949.8789,574.7656,278.75
营业税金及附加1,379.583,634.132,494.561,522.031,110.71
销售费用29,401.6679,020.6761,747.2343,306.7829,985.71
管理费用15,094.4336,178.1433,625.2215,991.118,562.72
财务费用-274.97-3,081.27-1,570.85-1,139.87-347.90
研发费用11,979.0450,880.2227,119.9918,323.606,066.68
资产减值损失----------
公允价值变动收益364.92-8,377.93-10,809.12-803.32-5,449.92
投资收益6,316.0621,912.5314,232.2710,306.405,205.80
其中:对联营企业和合营企业的投资收益6,437.6616,485.8912,766.578,215.954,646.75
汇兑收益----------
三、营业利润199,286.05412,539.74298,078.13185,802.84132,520.97
加:营业外收入2.45127.0910.477.351.19
减:营业外支出53.90658.69158.03109.9020.93
其中:非流动资产处置损失----------
四、利润总额199,234.61412,008.15297,930.56185,700.30132,501.23
减:所得税费用30,212.4850,159.4643,621.3025,085.0119,004.55
五、净利润169,022.12361,848.68254,309.27160,615.29113,496.68
归属于母公司所有者的净利润167,995.13361,818.66252,454.03159,787.52112,862.32
少数股东损益1,026.9930.031,855.23827.77634.36
六、每股收益
基本每股收益(元/股)1.19702.57811.79881.13851.2867
稀释每股收益(元/股)1.19702.57811.79881.13851.2867
七、其他综合收益8.23-50.44-22.36-56.43-19.02
八、综合收益总额169,030.36361,798.25254,286.90160,558.85113,477.66
归属于母公司所有者的综合收益总额168,005.17361,780.13252,439.21159,739.83112,853.00
归属于少数股东的综合收益总额1,025.1818.121,847.70819.03624.66
下载全部历史数据到excel中 返回页顶